151 related articles for article (PubMed ID: 16379547)
41. Rapid detection of large expansions in progressive myoclonus epilepsy type 1, myotonic dystrophy type 2 and spinocerebellar ataxia type 8.
Krysa W; Rajkiewicz M; Sułek A
Neurol Neurochir Pol; 2012; 46(2):113-20. PubMed ID: 22581592
[TBL] [Abstract][Full Text] [Related]
42. Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg disease.
Berrechid AG; Bendjebara M; Bouteiller D; Nasri A; Peuvion JN; Marie Y; Baulac S; Mrabet S; Ribierre T; Cazeneuve C; Imenkacem ; Leguern E; Gouider R
Epileptic Disord; 2019 Aug; 21(4):359-365. PubMed ID: 31368437
[TBL] [Abstract][Full Text] [Related]
43. Molecular background of progressive myoclonus epilepsy.
Lehesjoki AE
EMBO J; 2003 Jul; 22(14):3473-8. PubMed ID: 12853462
[TBL] [Abstract][Full Text] [Related]
44. Unverricht-Lundborg disease: homozygosity for a new splicing mutation in the cystatin B gene.
Pinto E; Freitas J; Duarte AJ; Ribeiro I; Ribeiro D; Lima JL; Chaves J; Amaral O
Epilepsy Res; 2012 Mar; 99(1-2):187-90. PubMed ID: 22154554
[TBL] [Abstract][Full Text] [Related]
45. Allelic heterogeneity of Mediterranean myoclonus and the cystatin B gene.
Labauge P; Ouazzani R; M'Rabet A; Grid D; Genton P; Dravet C; Chkili T; Beck C; Buresi C; Baldy-Moulinier M; Malafosse A
Ann Neurol; 1997 May; 41(5):686-9. PubMed ID: 9153533
[TBL] [Abstract][Full Text] [Related]
46. Progressive myoclonus epilepsy of Unverricht-Lundborg type.
Lehesjoki AE; Koskiniemi M
Epilepsia; 1999; 40 Suppl 3():23-8. PubMed ID: 10446747
[TBL] [Abstract][Full Text] [Related]
47. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression.
Franceschetti S; Sancini G; Buzzi A; Zucchini S; Paradiso B; Magnaghi G; Frassoni C; Chikhladze M; Avanzini G; Simonato M
Neurobiol Dis; 2007 Mar; 25(3):675-85. PubMed ID: 17188503
[TBL] [Abstract][Full Text] [Related]
48. Univerricht-Lundborg disease: underdiagnosed in the Netherlands.
de Haan GJ; Halley DJ; Doelman JC; Geesink HH; Augustijn PB; Jager-Jongkind AD; Majoie M; Bader AJ; Leliefeld-Ten Doeschate LA; Deelen WH; Bertram E; Lehesjoki AE; Lindhout D
Epilepsia; 2004 Sep; 45(9):1061-3. PubMed ID: 15329070
[TBL] [Abstract][Full Text] [Related]
49. Negative myoclonus causes locomotory disability in progressive myoclonus epilepsy type EPM1- Unverricht-Lundborg disease.
Vogt H; Baisch T; Mueller-Pfeiffer C; Mothersill IW
Epileptic Disord; 2023 Jun; 25(3):297-308. PubMed ID: 37536959
[TBL] [Abstract][Full Text] [Related]
50. Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease.
Lucchino V; Scaramuzzino L; Scalise S; Grillone K; Lo Conte M; Esposito C; Aguglia U; Ferlazzo E; Perrotti N; Malatesta P; Parrotta EI; Cuda G
Stem Cell Res; 2021 May; 53():102329. PubMed ID: 33865103
[TBL] [Abstract][Full Text] [Related]
51. Primary motor cortex alterations in a compound heterozygous form of Unverricht-Lundborg disease (EPM1).
Danner N; Julkunen P; Könönen M; Hyppönen J; Koskenkorva P; Vanninen R; Lehesjoki AE; Kälviäinen R; Mervaala E
Seizure; 2011 Jan; 20(1):65-71. PubMed ID: 21075014
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy.
Kinrions P; Ibrahim N; Murphy K; Lehesjoki AE; Järvela I; Delanty N
Neurology; 2003 Apr; 60(8):1394-5. PubMed ID: 12707458
[No Abstract] [Full Text] [Related]
53. Advances in the genetics of progressive myoclonus epilepsy.
Delgado-Escueta AV; Ganesh S; Yamakawa K
Am J Med Genet; 2001; 106(2):129-38. PubMed ID: 11579433
[TBL] [Abstract][Full Text] [Related]
54. Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease.
Ceru S; Rabzelj S; Kopitar-Jerala N; Turk V; Zerovnik E
Med Hypotheses; 2005; 64(5):955-9. PubMed ID: 15780491
[TBL] [Abstract][Full Text] [Related]
55. The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1.
Singh S; Hämäläinen RH
Cells; 2024 Jan; 13(2):. PubMed ID: 38247861
[TBL] [Abstract][Full Text] [Related]
56. White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice.
Manninen O; Koskenkorva P; Lehtimäki KK; Hyppönen J; Könönen M; Laitinen T; Kalimo H; Kopra O; Kälviäinen R; Gröhn O; Lehesjoki AE; Vanninen R
Radiology; 2013 Oct; 269(1):232-9. PubMed ID: 23788720
[TBL] [Abstract][Full Text] [Related]
57. [Unverricht-Lundborg disease].
Naito H; Wachi M
Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):189-93. PubMed ID: 12483858
[No Abstract] [Full Text] [Related]
58. Alterations of motor cortical excitability and anatomy in Unverricht-Lundborg disease.
Danner N; Julkunen P; Hyppönen J; Niskanen E; Säisänen L; Könönen M; Koskenkorva P; Vanninen R; Kälviäinen R; Mervaala E
Mov Disord; 2013 Nov; 28(13):1860-7. PubMed ID: 23925991
[TBL] [Abstract][Full Text] [Related]
59. [Unverricht-Lundborg disease (PME1)].
Genton P
Rev Neurol (Paris); 2006 Sep; 162(8-9):819-26. PubMed ID: 17028542
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
